Drug recall · February 1, 2017
Temozolomide Capsules recall
Why: Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Temozolomide Capsules, 250 mg, 5-count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA, NDC 0378-5265-98.
- Lots / codes
LOT #: 2006912, Exp 02/18
- Quantity
- 588 bottles
- Company
- Mylan LLC., Caguas, PR
- Distribution
- Nationwide in the USA
- Initiated
- December 20, 2016 · Voluntary: Firm initiated
- Classified
- January 25, 2017
- Reported
- February 1, 2017
- Ended
- January 25, 2018
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Temozolomide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.